Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xingqi tannikaer
- Development stage
- Phase 2
- Lead developer
- Xinjiang Uygur Pharmaceutical
- Administration
- Oral
01
Overview
**Xingqi tannikaer** is an oral Uyghur traditional-medicine capsule developed by Xinjiang Uygur Pharmaceutical for gastrointestinal symptoms and constipation. Public clinical-trial records include a completed Phase II study in functional constipation and a recruiting Phase III confirmatory study for decreased appetite, abdominal distension, and constipation associated with abnormal mucus temperament. Published quality-control work identifies borax, aloe, pepper, and henbane among the formulation's constituents. Its molecular pharmacology and specific biological targets have not been publicly established.
- Other names
- Xing Qi Tan Ni Ka Er CapsuleXingqi Tanikal capsuleXingqi TannikaerXingqi Tannikaer Capsule行气坦尼卡尔胶囊
Beyond the preview
Go deeper on xingqi tannikaer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xingqi tannikaer.